HealthX Connect Osaka 2026

1 Jul 2026 | Osaka, Japan

CanSense Ltd

Company (SME/startup) / 中小企業・スタートアップ

www.cansenseltd.comSwansea, United Kingdom
48 profile visits

About

CanSense Ltd is a Wales-based med-tech company developing blood-based diagnostics for early cancer detection. Built on research from Swansea University, the company combines Raman spectroscopy and AI to analyse biological signatures in standard blood samples, with an initial focus on bowel cancer and a broader platform for additional cancer indications. CanSense is advancing its technology through clinical validation, regulatory development, and strategic partnerships to deliver accessible, affordable, and scalable diagnostic solutions for the UK and global healthcare markets.

Business Domain / 分野

Healthcare / ヘルスケアMedical devices / 医薬機器

Business Type / 業種

R&D / 研究開発Academia, Techtransfer / 学術、技術移転Trading Company, Sales Agent, Distributor / 商社、販売代理店、流通業者

Disease Area/疾患領域

Health maintenance / 健康維持Oncology/がんGastroenterology/消化器

Technologies / 技術

Biomarkers / バイオマーカーAI・Data analysis / AI・データ分析Pharmacological/Safety evaluation / 薬効・薬理・安全性評価

Additional Information

Requested business parter / ご希望のビジネスパートナー 

Healthcare/ヘルスケアPharmaceuticals / 医薬品R&D/研究開発CRO /開発業務受託Academia, techtransfer/学術、技術移転Public organisations, Clusters / 公的機関・クラスター等Health maintenance / 健康維持Oncology/がんGastroenterology/消化器Food testing / 食品検査

Representatives

Clinical Director

CanSense Ltd

Marketplace (4)

  • Investment

    Pre-Series A equity fundraise

    CanSense seek equity investment of up to £2MGBP/ JPY428M for expansion into global markets.

    • Series A | Scale business
    Author

    Clinical Director at CanSense Ltd

  • Service

    Colorectal cancer diagnostic testing

    CanSense-CRC vaildated blood test for accurate and cost effective detection of spectral signatures of colorectal cancer and high-risk adenomas in blood serum.

    • Testing & Analysis
    • Research & Development
    Author

    Clinical Director at CanSense Ltd

  • Project cooperation

    Clinical trial sites for clinical performance Study in colorectal cancer

    We seek healthcare facilities and colonoscopy provider sites to support clinical trial recruitment towards CanSense PMDA approvals.

    • Technical
    • Capital contribution
    • Strategic Partnership
    • Completing the consortia
    • Consortium seeks Partners
    • Technological contribution
    • Design - setting the project scope
    Author

    Clinical Director at CanSense Ltd

  • Service

    QA testing service

    Raman spectroscopy liquid testing solution for impurity detection and QA release contracting.

    • Testing & Analysis
    • Research & Development
    Author

    Clinical Director at CanSense Ltd